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Abstract
Background: Most European countries are ethnically and culturally diverse. Globally, cardiovascular
disease (CVD) is the leading cause of death. The major risk factors for CVD have been well established.
This picture holds true for all regions of the world and in different ethnic groups. However, the prevalence
of CVD and related risk factors vary among ethnic groups.
Methods: This article provides a review of current understanding of the epidemiology of vascular disease,
principally coronary heart disease (CHD), stroke and related risk factors among populations of Sub-Sahara
African descent (henceforth, African descent) in comparison with the European populations in Europe.
Results: Compared with European populations, populations of African descent have an increased risk of
stroke, whereas CHD is less common. They also have higher rates of hypertension and diabetes than
European populations. Obesity is highly prevalent, but smoking rate is lower among African descent
women. Older people of African descent have more favourable lipid profile and dietary habits than their
European counterparts. Alcohol consumption is less common among populations of African descent. The
rate of physical activity differs between European countries. Dutch African-Suriname men and women are
less physically active than the White-Dutch whereas British African women are more physically active than
women in the general population. Literature on psychosocial stress shows inconsistent results.
Conclusion: Hypertension and diabetes are highly prevalent among African populations, which may
explain their high rate of stroke in Europe. The relatively low rate of CHD may be explained by the low
rates of other risk factors including a more favourable lipid profile and the low prevalence of smoking. The
risk factors are changing, and on the whole, getting worse especially among African women. Cohort
studies and clinical trials are therefore needed among these groups to determine the relative contribution
of vascular risk factors, and to help guide the prevention efforts. There is a clear need for intervention
studies among these populations in Europe.
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Globally, cardiovascular disease (CVD) is the leading
cause of death [1]. This is particularly so in Europe, where
CVD has continued to maintain its lead for several dec-
ades [1], and this is reflected in Europe's multi-ethnic
populations [2]. The experiences of CVD mortality, mor-
bidity and risk factors vary hugely among ethnic groups
[2-6]. This is creating challenges for public health, epide-
miology and clinical care.
Populations of sub-Saharan African descent (henceforth
African descent) are at an increased risk of developing
stroke compared with European descent populations
(henceforth White) [2-4]. The patterning of these health
inequalities is complex. There have been different sugges-
tions on the possible causes of these inequalities, with
some emphasising the genetic underpinning of such ine-
qualities [7] and others arguing that ethnic differences in
health are mainly determined by socio-economic inequal-
ities [8-11]. Understanding the reasons behind the excess
risks is crucial for addressing ethnic inequalities in health.
Data by indicators of ethnic group are needed to establish
the extent of health inequalities and inequity in health
service provision.
This article provides a review of current understanding of
the epidemiology of vascular disease, (principally coro-
nary heart disease (CHD) and stroke), related risk factors
(i.e. hypertension, diabetes, abnormal lipids, smoking
and alcohol intake, obesity, dietary patterns, physical
inactivity and psychosocial stress), possible causes and
management, and critical gaps of knowledge among pop-
ulations of Africa populations in Europe. We have chosen
the risk factors found to be most important by the Inter-
Heart study, which are widely recognised as the major risk
factors for CHD. Collectively, these risk factors accounted
for 90% of the population-attributable risk (PAR) in men
and 94% in women [12]. In addition, the paper also sum-
marises the putative emerging CVD risk factors, access and
quality of care and provides recommendations for future
work among these populations in Europe. The key ques-
tions to be addressed are: what is the burden of CVD and
its related risk factors among populations of African
descent in Europe? What are the possible reasons for the
increased burden? And what are the differences in the
management of risk factors for CVD between populations
of African descent and their European White counter-
parts?
Methods
Data from individual studies and systematic review arti-
cles known to the authors were examined. Electronic data-
bases (MEDLINE, EMBASE and Google Scholar) searchers
were also performed using combinations of the key terms
'Africans', 'African Caribbean', 'West Africans', 'Black' and
'ethnic minority groups', and were combined with cardio-
vascular diseases and related various risk factors. Refer-
ence lists were reviewed to identify additional relevant
data sources. Key references were examined by first and
second authors. Articles used in this review consist of
scholarly papers published between 1960 until February
2009.
Note on ethnicity
There is no consensus on appropriate terms for the scien-
tific study of health by ethnicity, and published guidelines
are yet to be widely adopted. We have followed general
conventions used in Europe and, whenever appropriate,
the terminologies used in the original documents were
referred to [12]. The term 'ethnic minority group' refers to
minority non-European, non-White populations [12].
Ethnicity refers to the group individuals belong to as a
result of their roots, which include language, religion,
diet, and ancestry [12]. Different terms are used to refer to
populations of African descent living in different Euro-
pean countries [13]. African Caribbean refers to people,
and their offspring, with African ancestral origin but who
migrated to the UK via the Caribbean islands. Sub-Saha-
ran ('black') African refers to people, and their offspring,
with African ancestral origin who migrated via sub-Saha-
ran Africa. African Surinamese is used to refer to people
with African ancestral origins and their offspring who
migrated to the Netherlands via Suriname.
Populations of African descent in Europe
The migration of populations of African descent to Europe
has a long history, and the reasons of migration and the
subsequent relationship between the African migrants
and the European populations have been determined
largely by the order of the time. Britain, for example, has
a long history of contact with Africa [14]. The presence of
populations of African descent in Britain has been
reported since 200 AD [15]. Several hundred years after-
wards the influence of the Atlantic slave trade – one of the
darkest episodes in human history- began to be felt, with
the first group of West Africans being brought to the UK in
1555 [14]. By the last third of the 18th century, there were
an estimated 10,000 Africans in Britain [16], concentrated
mostly in cities such as London.
The migration of the populations of African descent to
Europe in the mid-20th century was mainly due to the
need to rebuild Europe following World War II. The
demands of an expanding economy and the development
of the welfare state required labour on a scale that could
not be provided locally. The economic downturn and the
political instability in the last few decades in many African
and Caribbean regions also contributed to this flow of
migration from Africa and the Caribbean to Europe.Page 2 of 17
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European destination where the Africans migrated. People
from the Commonwealth nations of Africa such as
Nigeria and Ghana migrated to Britain whereas those
from Francophone countries such as Ivory Coast and Sen-
egal migrated to France. Similar patterns were also
observed among the Caribbean groups such as Jamaicans
moving to the UK and Surinamese moving to the Nether-
lands [17]. These patterns of migration might be partly
due to the influence of colonial heritage such as language
familiarity and similar educational systems.
Estimating future population size of populations of Afri-
can descent is complicated and has to take into consider-
ation not only fertility, mortality and net migration, but
also ethnic identity [2]. What is obvious is that many of
these populations are ageing and the burden of CVD will
increase. This has major implications for health and social
care.
Epidemiology of cardiovascular disease in populations of 
African descent in Europe
Except for the UK, and a few reports in the Netherlands,
information on CVD among populations of African
descent is limited in Europe. Hence, this outline will be
largely based on data from the UK and the Netherlands.
The summarised results are given in Table 1. These data
suggest that these populations have a high incidence of
stroke [2-4], whereas CHD is less common [2-4]. These
findings are consistent with the reports in the USA [16].
Despite the higher rate of stroke, survival after stroke has
been shown to differ between different European coun-
tries. One UK study, for example, found better survival
rates among populations of African descent than in the
White group [18]. By contrast, a recent Dutch report
found stroke survival rates in both short- and long-term to
be poorer in all ethnic minority groups than in the White-
Dutch population [19].
The fact that studies have found a lower rate of CHD in
populations of African descent than in their European
counterparts [2,3] does not imply that CHD is uncom-
mon among these populations. Heart disease still remains
one of the single most important causes of death among
these populations in Europe. In fact, recent data from the
UK indicate that the CHD advantage is diminishing rap-
idly. Recent analyses by Harding and colleagues [6], span-
ning from 1979 to 2003, show very worrying trends. For
the first time Jamaican born women had a higher directly
age-standardised CHD death rate than those born in Eng-
land and Wales. In 1979–83, the age-standardised rate of
CHD was lower in Jamaican born women than those born
in England and Wales (Rate ratio = 0.63, 95% CI: 0.52,
0.77). In 1999–2003, they were more likely than those
born in England and Wales to have CHD (Rate ratio =
1.23, 95% CI: 1.06, 1.42). The gap between Jamaican
born men and those born in England and Wales is also
closing rapidly. The age-standardised rate ratio of CHD in
Jamaican born men in 1979–83 was 0.45 (95% CI: 0.40,
0.50). In 1999–2003, the rate had increased to 0.81 (95%
CI: 0.73, 0.90). The convergence of CHD rates among the
UK African populations is reminiscent of what happened
in the USA where African Americans now have a higher
rate than the White Americans, reversing the previous pat-
tern [20]. These changing trends may be due to the fact
that the CHD rate has declined more rapidly in White
populations than in ethnic minority populations.
Established vascular risk factors
The causes of the excess stroke morbidity and mortality,
and the lower CHD burden among populations of African
descent are incompletely understood. The available evi-
dence indicates that the excess CVD morbidity and mor-
tality may due to several factors including the higher
prevalence of CVD risk factors such as hypertension and
diabetes [8,21-29].
The major risk factors for CVD have been well established.
These include hypertension, diabetes, abnormal lipids,
smoking, obesity, low consumption of fruits and vegeta-
bles, alcohol intake, physical inactivity and psychosocial
stress. This picture holds true for men and women, in all
age groups, all regions of the world and in all ethnic
groups [11,30]. The majority of patients who develop
CVD have at least one of these risk factors. In the INTER-
HEART study [11], these nine risk factors provided a PAR
of 97.4% for myocardial infarction for the participants of
African descent. The INTERHEART Africa study also
showed that five modifiable risk factors (hypertension,
diabetes, abdominal obesity, elevated ApoB/ApoA-1 ratio
and current/former tobacco smoking) provided PAR of
89.2% for a first-time myocardial infarction [31].
Hypertension
Burden
Hypertension is highly prevalent among populations of
African descent in Europe [24,25] and North America
[26,32], and deserves a special detailed outline in these
populations. The increased prevalence of hypertension
among these populations in Europe appears to be a major
contributor to the observed elevated stroke risk [2,33]. In
the UK, for example, there is a consensus that the preva-
lence of hypertension is three to four times higher in the
population of African descent than in White people
[24,33-35]. This holds for both men and women. A higher
prevalence of hypertension has also been reported among
populations of African descent in other European coun-
tries such as the Netherlands [25]. The recent SUNSET
study found that African-Surinamese men were over two
times and African-Surinamese women were nearly fourPage 3 of 17
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Globalization and Health 2009, 5:7 http://www.globalizationandhealth.com/content/5/1/7Table 1: Comparison of disease outcomes and risk factor levels among populations of African descent in the UK and the Netherlands
Men Women
African 
Caribbeans
Sub-Saharan 
Africans
African 
Surinamese
African 
Caribbeans
Sub-Saharan 
Africans
African 
Surinamese
Disease 
outcomes
Stroke [2-5] + + + + + +
Coronary heart 
disease [2-5]
- - - - - -
Type II diabetes 
[26,27,34,71]
+ + + + + +
Chemical 
measurement 
risk factors
High total 
cholesterol* 
[26,89,71]
- - - - - -
Low HDL 
cholesterol 
[26,89,71]
- - - - = -
ApoA-1 [89] = =
ApoB [89] - -
Physical 
measurement 
risk factors
Hypertension 
[23,24]
+ + + + + +
Obesity (BMI > 30 
kg/m2) 
[23,24,94,97]
= - = + + +
Abdominal obesity 
[23,24,94]
- - - + + +
Self-reported 
risk factors
Current smoking 
[93,94]
= - + = - -
Alcohol 
consumption 
[93,94]
- - - - - -Page 4 of 17
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have hypertension [25]. These observations fit with the
higher rates of stroke among these populations in Europe
[2-5]. African Americans also show an increase in the
prevalence of hypertension compared to their White
American counterparts in the USA [32,36]. In Africa itself,
hypertension is rapidly becoming a major public health
burden [37] particularly in urban centres [38,39]. The
emerging data (for example 2004) show hypertension
prevalence ranging from 16.5% in urban Eritrea to 33.4%
in urban Ghana [38,39]. The increasing prevalence of
hypertension reflects well on the increasing CVD mortal-
ity in Africa [40,41].
In addition to a high resting blood pressure (BP), noctur-
nal BP fall (i.e. daytime BP minus night-time BP) has been
shown to be lower in populations of African descent in
Europe than their White counterparts [42]. A diminished
nocturnal decline in BP has independently been associ-
ated with increased stroke [43,44], left ventricular hyper-
trophy [45,46] and progression of renal damage [47]. All
these conditions are highly prevalent in populations of
African descent in Europe [2,48-50].
Causation
The reasons for the higher prevalence of hypertension
among populations of African descent in Europe and
North America have been well debated. To date, there are
still no clear answers as to why hypertension is more com-
mon among these groups than among their European
counterparts. Several explanations and speculations have
been proposed including genetic factors [51,52]. Low
renin levels found among African-Americans have been
hypothesised to be the result of a genetic 'maladaptation'
which benefited their earlier African-American ancestors
to survive the ordeal of a transatlantic voyage under slav-
ery, but later turned out to be harmful to survival due to
the resultant avid salt retention [53]. Despite rigorous crit-
icisms and unreliable data sources, this hypothesis has
sustained some considerable degree of popular and scien-
tific acceptance [54]. The issue of the link between skin
colour and hypertension is even more complex. The posi-
tive relationship between dark skin and BP in some Amer-
ica studies has led some to suggest that the link is genetic
[55]. In contrast, others have argued that it is a manifesta-
tion of the stress and social pressure of having a dark skin
that causes the high BP [56].
The BP differences between the African and European
descent populations may, in part, relate to environmental
factors that may impact health, such as the residing coun-
tries' national context in terms of opportunities in life,
psychosocial and lifestyle factors that may underline these
differences. Clearly, one cannot underestimate the impor-
tance of genetics on health inequalities between popula-
tions. However, the importance of social structures, the
communities where people live, and social factors cannot
be underestimated [57,58]. The use of genetic mecha-
nisms to explain familial aggregation of hypertension is a
very good example. It is highly possible that the familial
aggregation of hypertension might merely reflect environ-
mental exposures shared within families, which, in turn,
might increase the risk of developing hypertension rather
than genes per se. In Cuba where ethnic barriers are said
to be small, the ethnic differences in BP and management
were shown to be small [59].
Another difficulty in explaining the BP differences
between the African and European descent populations
may relate to a general lack of recognition about the
remarkable heterogeneity within the African descent
groups in Europe and North America [13]. The disadvan-
tages of the populations of African descent are not fixed
across countries, generations, or across different African
Physical inactivity 
(non-adherence to 
recommendations) 
[66,93]
= + + - = +
Consumption of < 
5 portions of fruit 
and vegetables* 
[93,110]
- - - ** - - - **
Psychosocial stress 
[26,122-125]
inconsistent inconsistent inconsistent inconsistent
- Lower risk than White European population
+ higher risk than White European population
= comparable risk to White European population
* applied only to the non-UK born
** the Dutch group were based on overall diet quality
Table 1: Comparison of disease outcomes and risk factor levels among populations of African descent in the UK and the Netherlands Page 5 of 17
(page number not for citation purposes)
Globalization and Health 2009, 5:7 http://www.globalizationandhealth.com/content/5/1/7identities [13,23]. Recent emerging data are beginning to
shed more light on the huge differences within the popu-
lations of African descent [22,23,60-62]. Cooper and col-
league [22], for example, examined patterns of BP
distribution in different ethnic groups across three conti-
nents and found a wide variation in the prevalence of
hypertension both within and between the populations of
African and European descent. The rates among African
populations were not unusually high when compared
internationally. They therefore suggest that the impact of
environmental factors among African and European pop-
ulations may have been under-appreciated. The recent UK
studies have also revealed important heterogeneity in BP
patterns between children and adults among different eth-
nic groups [24,60,61]. In children of African descent, BP
levels were either lower [60] or similar [61] to their White
counterparts in the UK. In adults, BP levels were higher in
people of African descent than in White people [24]. The
emerging findings clearly favour environmental or an
interaction between genetics and environmental factors
rather than only genetic factors per se, for it is hard to
imagine genetic factors where the effect is delayed to later
adult life [61]. The findings also suggest that inferences
from cross-sectional studies done in certain geographic
areas with different socio-cultural, economic, political
and historical context cannot be extrapolated as logical
benchmarks for other areas. As a result, some commenta-
tors have challenged researchers to re-examine the evi-
dence [63].
Management
One of the main central focuses of the primary prevention
of CVD has been increasing awareness, treatment and
control of patients with hypertension. This has had a pos-
itive impact on CVD prevention in many countries
[26,64,65], especially in the USA where the effort had
been greatest. [26,65] Detection and treatment of hyper-
tension appears to be similar or higher among popula-
tions of African descent than their White counterparts in
Europe [34,66]. However, BP control tends to be poorer
among African populations than their White counterparts
[34,66]. In the SUNSET study, African-Surinamese men
(odds ratio = 0.3, 95% CI: 0.1, 0.7) and women (odds
ratio = 0.5, 95% CI: 0.3, 0.9) were less likely than their
White-Dutch counterparts to get their hypertension ade-
quately controlled [66]. The reasons for the low BP con-
trol among the populations of African descent are unclear,
but an inadequate drug therapy owing to individual sen-
sitivity to different drugs, non compliance with therapy,
clinicians' perceptions, organisational pitfalls and cultural
factors may contribute to the poor BP control found
among these populations [66-68].
With concerted efforts, better BP control could be
achieved for the populations of African descent in Europe
[69,70]. In some trials, when medications and provider
services were provided free of charge as in the Hyperten-
sion Detection and Follow-up Program, African-American
men treated with the intensive "Stepped-Care Approach"
actually benefited more than White Americans [70]. In a
recent Jackson Heart Study report, BP control rate in Afri-
can Americans was 66.4% [69]. This was comparable to
the control rate of White Americans in NHANES study
[26]. The control rate in African Americans in the Jackson
Heart study [67] far exceeds rates reported among both
African and European descent populations in many Euro-
pean countries [34,64,65].
Type 2 diabetes mellitus
Burden
Populations of African descent have an increased risk of
type II diabetes compared with their European descent
counterparts in Europe [27,28,34,71]. In the Health Sur-
vey for England (HSE) 1999, the age-standardised risk
ratio for diabetes was 2.5 for African Caribbean men and
4.2 for African Caribbean women [27]. Recent Diabetes
UK estimates for prevalence rates indicate that 17% of the
African Caribbean community in the UK has type II dia-
betes compared with 3% of the UK general population
[28]. The Dutch data also show a higher prevalence of
type II diabetes in African Surinamese than in the White-
Dutch group [71]. In a recent Dutch report [71], the age-
standardised prevalence of type II diabetes in African Suri-
namese was 14.2% compared with 5.5% in White-Dutch
individuals. The difference was more pronounced in the
older age group. In the age-group 35 to 44 years, the sex-
adjusted odds ratio was 1.9 (95% CI: 0.8, 4.6) for African
Surinamese as compared to the White-Dutch group. In the
age group 45 to 60 years, the sex-adjusted odds ratio was
2.7 (95% CI: 1.6, 4.6) for African Surinamese. Higher
prevalence of diabetes had also been reported among Afri-
can Americans than among White American in the USA
[72]. Evidence also suggests that the prevalence of diabe-
tes is rising rapidly in Africa with prevalence rates ranging
from 0.7% in Cameroon to 8.8% in South Africa among
rural dwellers, and from 1.7% in Cameroon to 10.4 in
Sudan among urban dwellers [73]. In a recent review
among Ghanaians and Nigerians, diabetes seemed rare in
urban Ghana in 1963 (0.2%) and in urban Nigeria in
1985 (1.65%). However, in 1998, the prevalence of diabe-
tes among Ghanaians was 6.3% and 6.8% among Nigeri-
ans [74].
Causation
Several factors have been linked to the increased preva-
lence of type II among populations of African descent
such as increasing obesity, insulin resistance, physical
inactivity and unhealthy diet [75-77]. Obesity is an
important contributing factor to increased insulin con-
centrations and decreased insulin sensitivity [78]. Evi-Page 6 of 17
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type II diabetes increases progressively from a BMI of > 20
kg/m2 [79-81]. Obesity is highly prevalent among popula-
tions of African descent in Europe, particularly among
women (see section 4.4). In Lipton and colleagues' stud-
ies, the excess risk of type II diabetes in African Americans
relative to White Americans increased with increasing
level of obesity, particularly for African Americans women
[82]. Insulin resistance was also higher in African Carib-
beans than in Whites [77]. Insulin resistance was shown
to increase the risk of both type II diabetes [83] and CVD
[84].
Management
Several trials have shown that reducing the progression to
type II diabetes in high risk groups is possible and practi-
cal irrespective of ethnicity. The American diabetes pre-
vention programme [85], the Da Qing study in China
[86], and the Finnish diabetes prevention study [87], all
showed that the prevention of diabetes is feasible through
diet and exercise interventions in people with impaired
glucose tolerance. In the UK Prospective Diabetes Study
(UKPDS), after adjusting for age, sex, baseline characteris-
tics, treatment allocation, and change in weight, there
were no consistent ethnic differences in mean change in
fasting plasma glucose or HbA1c during the nine year fol-
low up. African Caribbean patients maintained the most
favourable lipid profiles, but hypertension developed in
more African Caribbean patients than in White patients
[88]. These data demonstrate that in a clinical trial, Afri-
can Caribbeans did just as well or better than White peo-
ple, even if their burden of the disease is high. A UK
cohort study [89] showed lower prevalence of microvas-
cular and macrovascular complications in African Carib-
beans compared to White people over 20 years of follow
up. African Caribbeans with type II diabetes maintained a
low risk of heart disease [89].
The evidence to date, however, suggests that diabetes con-
trol is poorer in some populations of African descent than
their European counterparts in the UK. In the Wands-
worth Prospective Diabetes Study in the UK, the propor-
tion of patients reaching treatment targets for HbA1c was
significantly lower in the African Caribbeans than in
White patients [90]. This may, in part, relate to poor
knowledge about the disease, complications, and the
importance of self management, as a result of poor com-
munication and provision of culturally inappropriate
information [91]. A study at the Manchester diabetes cen-
tre showed deficiencies in the care of African Caribbean
patients compared with White patients [92].
Lipids
Burden
Populations of African descent, while having a high risk of
hypertension and diabetes, have a more favourable lipid
profile. In a UK population-based study that compared
the lipid profile of ethnic minority groups and the general
population, African Caribbeans were demonstrated to
have lower levels of total cholesterol and triglycerides and
higher levels of HDL cholesterol [27]. The Whitehall study
of London-based civil servants reported significantly
lower cholesterol, Apo B and triglyceride levels in African
Caribbeans compared to White people, after adjusting for
potentially confounding factors [93]. African Caribbeans
had higher HDL cholesterol levels in every grade of
employment than their White counterparts. The Dutch
data also indicate that the African populations in the
Netherlands have a more favourable lipid profile than
their White-Dutch counterparts [71]. Notwithstanding
this, recent evidence suggests that the favourable lipid
profile among African populations in Europe is not uni-
form across all the populations of African descent. The
analyses of the UK-born African Caribbean group indicate
that lipid measures did not differ from that of the general
population, except for higher HDL levels in UK-born Afri-
can Caribbean men [94]. The better lipid profile among
populations of African descent suggests that this factor
may not contribute to their increased risk of CVD. This
might change if the lipid profile deteriorates over time.
Causation
The reasons for the favourable lipid profile among popu-
lations of African descent are unclear. Some have sug-
gested that these differences in lipoprotein levels are
associated with genetic variations in hepatic lipase, such
as populations of African descent having a higher preva-
lence of less active hepatic lipase phenotype and a lower
prevalence of central obesity than European populations
for the same degree of BMI [95]. The lack of differences
between the UK-born African Caribbean group and the
UK general population suggests that environmental fac-
tors may be at work [94]. Older African Caribbean group
in the UK eat more traditional diets associated with a pro-
tective effect for CHD, with high fresh fruit and vegetable
content, but younger UK-born African Caribbeans have
greater energy intake from fat [96]. In addition, central
obesity is not uniformly low among all populations of
African descent [97,98]. In the Dutch SUNSET study, Afri-
can Surinamese women were more centrally obese than
their White-Dutch counterparts [98].
Management
Evidence from primary and secondary prevention trials
has established that lowering LDL-cholesterol levels will
lead to a substantial reduction in the risk of CVD events.
Despite this, there is a paucity of data on ethnic differ-Page 7 of 17
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one USA study, African Americans were less likely than
White Americans to be treated and controlled for dyslipi-
demia [99]. Ethnic inequalities were abolished after dif-
ferences in healthcare access had been adjusted for [99].
The loss of the comparatively favourable lipid profile
among the UK-born African Caribbeans clearly indicates
the need to monitor lipid profiles among these popula-
tions in Europe [96].
Overweight and obesity
Burden
Overweight and obesity are highly prevalent among pop-
ulations of African descent in Europe, especially among
women [24,25,97,98,100]. In the HSE 2004 [97], the
prevalence of overweight and obesity were 32.4% and
32.1% in the African Caribbean women and 31.3% and
38.5% in the Sub-Saharan African women as compared
with 33.9% and 23.2% in women in the general popula-
tion. Higher rates of raised waist to hip ratio (WHR) and
waist circumference were also found among African Car-
ibbean and Sub-Saharan African women than among
women in the general population. By contrast, African
Caribbean men had similar rates while Sub-Saharan Afri-
can men had lower rates of overweight and obesity than
their White male counterparts. The prevalence of raised
WHR and raised waist circumference were lower in both
African Caribbean and Sub-Saharan African men than in
their UK general population counterparts [97]. Higher
rates of overweight have also been found among African
Caribbean and Sub-Saharan African adolescents in the UK
[101]. Similar higher rates have also been reported among
African descent women in other European countries
[98,100]. In the SUNSET study [98], 33.4% of the African
Surinamese women were overweight and nearly 43% were
obese compared with 40.2% overweight and 14.3% obes-
ity in White-Dutch women. In their study comparing the
Ghanaian population in the Netherlands with their coun-
terparts in rural and urban Ghana, Agyemang and col-
leagues found Ghanaian migrants in the Netherlands to
have an overly higher prevalence of overweight and obes-
ity (men 69.1%, women 79.5%) than their urban (men
22.0%, women 50.0%) and rural (men 10.3%, women
19.0%) counterparts in Ghana [100]. Recent USA studies
also show a higher prevalence of overweight and obesity
among African American men and women compared with
their White American counterparts in the USA [102]. Evi-
dence also indicates that overweight and obesity are on
the increase in Africa especially among women. A recent
systematic review found that the prevalence of obesity in
urban West Africa more than doubled (114%) over 15
years, with the increase accounted for almost entirely in
women [103].
Causation
The possible reasons for the increased overweight and
obesity among populations of African descent women are
unclear. Obesity is, however, the result of an imbalance
between energy intake and energy expenditure. Increases
in the intake of fat and sugar as well as sedentary lifestyles
have been linked to the rising epidemic of obesity
[104,105]. In Luke et al's study, between 60% and 80% of
the variance in adiposity between Nigerians and African
Americans was explained by differences in activity energy
expenditure or total daily energy expenditure [106]. In
Harding and colleagues' work, excess overweight among
African Caribbean and Sub-Saharan African girls in the
UK was associated with adverse dietary behaviours [101].
Interestingly, current data seem to suggest that African
Caribbean and Sub-Saharan African older women have
favourable dietary behaviour, and do more physical activ-
ity than their White counterparts [97] despite their higher
prevalence of obesity.
Cultural perceptions regarding overweight and obesity
may also play a role in the increasing prevalence of over-
weight and obesity among these populations. In most
African societies, being overweight or obese was and still
is, at least in some part, associated with prestige, happi-
ness and good healthy living, especially in women [107].
Many older people of African descent in Europe came at a
time when these perceptions were very strong. It is possi-
ble that they have held on to these perceptions in Europe,
which might be associated with a high rate of overnutri-
tion and subsequently higher prevalence of obesity [100].
This, indeed, requires further studies.
Management
The increasing prevalence of overweight and obesity
among populations of African descent especially in
women underscores the urgent need to tackle this prob-
lem among these populations in Europe. Weight loss can
improve or prevent many of the obesity-related risk fac-
tors for CVD. The optimal management of overweight and
obesity begins with a combination of diet, exercise and
behavioral modification. Addressing the obesity problem
among populations of African descent may require cultur-
ally tailored approaches especially among the older gener-
ation. The perception of ideal body weight may differ
between the older groups and their European-born chil-
dren [108]. Hence obesity prevention initiatives need to
be culturally tailored to prevent potential conflict of per-
ceptions between the older and the younger groups. These
approaches need to be validated and assessed to consider
cultural acceptability, which is likely to affect uptake and
compliance.Page 8 of 17
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Burden
Physical inactivity represents an independent risk factor
for CVD [109] and exercise is recommended to prevent
CVD and promote and maintain healthy living [110,111].
The available data show important differences in physical
activity levels among different ethnic groups. Evidence
from the HSE 2004 shows that African Caribbean (31%)
and Sub-Saharan African (29%) women were more likely
than women in the general population (25%) to achieve
the recommendations of participating in activity of mod-
erate to vigorous intensity [97]. The rate in African Carib-
bean men (37%) and Sub-Saharan African men (35%)
were similar to the men in the general population (37%).
The Dutch data, [66] by contrast, suggest that African Suri-
namese were less likely than their White-Dutch counter-
parts to achieve the recommendations of participating in
physical activity.
Causes
The high rate of physical activity levels reported among
populations of African descent women in the UK contrasts
the higher rates of inactivity related conditions such as
obesity [97]. The reasons for this finding are unclear. It
may be that because many African descent women are
obese and have high rates of other risk factors such hyper-
tension and diabetes; they may be more motivated than
women in the general population to engage in physical
activities. It may also well be that the heath education
messages on physical activity are getting through to these
communities in the UK. The lower rate of physical activity
levels among African-Surinamese in the Netherlands may
relate to several factors such as cultural differences in the
representation of physical activity, the cost of engaging in
physical activity, and insufficient skills to carry out the rec-
ommendations. In one Amsterdam study, several Ghana-
ians and African Surinamese hypertensive patients
reported lacking sufficient skills and experience to carry
out some of the physical activities (e.g., swimming and
bicycle riding) recommended by their general practition-
ers (Beune E et al. unpublished data).
Management
A physically active lifestyle delivers significant physical
and mental health benefit. Regular physical activity is rec-
ommended in the early school years and throughout life.
However, the enablers and inhibitors of physical activity
may differ between ethnic groups due to differences in
social, cultural and individual factors. Strategies to
improve physical activity among populations of African
descent in Europe should be comprehensive and cultur-
ally tailored.
Dietary habits
Burden
Consumption of fruits and vegetables can protect against
the development of CVD [112,113]. High fat intake raises
cholesterol levels; and high cholesterol levels have been
associated with obesity, abdominal obesity, and type II
diabetes [114]. Dietary habits differ considerably among
ethnic groups. The available evidence seems to suggest
that fruit and vegetable intake is higher in populations of
African descent than their European counterparts in
Europe. In the HSE 2004 [97], African Caribbean men
(32%) and women (31%) and Sub-Saharan African men
(31%) and women (32%) were more likely than men
(23%) and women (27%) in the general population to
meet the recommended guidelines of consuming five or
more portions of fruit and vegetables a day. High fat
intake was also lower in the African groups than in the
general population. The use of salt in cooking was con-
versely higher in African Caribbean and Sub-Saharan Afri-
can men and women than in the general population. One
study in the Netherlands also found that African Suri-
namese group scored higher on overall diet quality than
the White-Dutch group [115]. Although African-Suri-
namese group scored higher on overall diet quality than
their White-Dutch counterparts, fruit and vegetable intake
were lower than recommended [115]. There are impor-
tant differences between the older adults and the younger
groups. In the HSE 2004, [97] the fruit intake among the
younger African Caribbean age group (16–34 years) was
similar to that of the general population. The older Afri-
can Caribbean age group, by contrast, had higher fruit and
vegetable intakes than their general population counter-
parts. Harding and colleagues also found that African Car-
ibbeans and Sub-Saharan Africans boys and girls were
more likely to skip breakfast and engage in other poor die-
tary practices than their White peers in the UK [116].
Causation
Following migration, many ethnic minority groups
change their eating habits, combining parts of their tradi-
tional diet with some of the less healthy elements of the
European diet [117]. Age and generation have been iden-
tified as the two major factors that determine the extent to
which ethnic minority groups change their diets [117]. A
number of studies in the UK, France and Spain have
reported some departures from traditional African and
African Caribbean diets following migration, especially
among the younger generations [118,119]. In France,
Caius and Benefice [118] found that the dietary habits of
the West Indian adolescents were similar to their French
peers. Others have, however, found no relationship
between age or acculturation and dietary habits [115].
Other factors that may influence dietary habits include the
proportion of income spent on food, availability of food,
religion, and food beliefs [117].Page 9 of 17
(page number not for citation purposes)
Globalization and Health 2009, 5:7 http://www.globalizationandhealth.com/content/5/1/7Management
Changing diets of ethnic groups have resulted in major
health concerns such as diabetes and obesity [117]. Post-
migration dietary changes, especially among the younger
age groups of African descent, together with the high rates
of diet-related conditions present a huge challenge in
reducing the risk of diet-related diseases among these
populations. The available data seem to suggest, however,
that the older people of African descent have favourable
dietary habits despite their high rates of dietary related
conditions such as obesity [97]. Although many people of
African descent may report maintaining their traditional
diet, it is possible that the preparation, serving practices,
and eating habits have changed after migration [117].
Many dietary assessment questionnaires have also not
been critically assessed for their suitability in these groups
[97]. Hence the nutrient intakes of these groups need to
be interpreted with caution. The mismatch between the
self-reported dietary behaviour and the dietary related
conditions clearly emphasise the need for further studies
to critical examine changes in food preparation, serving
practices and eating habits following migration among
these populations in Europe.
Cigarette smoking
Burden
Tobacco smoking is an established risk factor for CVD
through a variety of mechanisms [120]. There is an impor-
tant heterogeneity between the populations of African
descent in Europe. In the HSE 2004 [93] the rates of smok-
ing among African Caribbean (men 25%, women 24%)
were similar to that of the general population (men 24%,
women 23%). Sub-Saharan African men (21%) and
women (10%) had lower rates than that of the general
population. The Dutch study [98] found a higher preva-
lence of smoking among African-Surinamese men (56%)
than among White-Dutch men (44.9%). African Suri-
namese women (33.8%) were, however, less likely than
White-Dutch women (44.3%) to smoke.
Causation
The explanations for the different patterns of smoking
behaviour among populations of African descent are
unclear. Differences in culture, socio-economic status and
the level of acculturation may play a role. In most African
societies, it is socially unacceptable for women to smoke
and this may reflect the lower prevalence of smoking
reported among Sub-Saharan African women in the UK.
Socio-economic position in relation to smoking is incon-
sistent. In the HSE 1999 [27], the relationship of social
class and equivalised household income to cigarette
smoking was the same for women as for men in the gen-
eral population. However, among African Caribbeans,
there were no relationships between cigarette smoking
and either social class or household income among
women.
Management
Intensive behavioural interventions such as individual
counselling, group counselling, telephone counselling
and minimal clinical intervention (brief advice from a
healthcare worker) can result in substantial increases in
smoking cessation. Smoking cessation interventions may
yield different results in smokers of ethnic minority
groups. Effective strategies are needed to reduce tobacco
use among populations of African descent in Europe, and
thus diminish their burden of tobacco-related diseases
and deaths [121]. Given the huge heterogeneity within
the populations of African descent, preventive pro-
grammes may need to be culturally tailored to have an
effect. Producing culturally sensitive information may
help to raise awareness of the additional links between
tobacco use and heart disease, oral cancers and respiratory
disease [122].
Alcohol consumption
Burden
Epidemiological studies have suggested that heavy drink-
ing constitutes a severe risk for CVD, but that low levels of
consumption can have a protective effect against CHD
mortality [123,124]. There has been little research on
alcohol consumption among minority ethnic groups in
Europe, and recent studies suggest that consumption lev-
els tend to be lower among these groups than among
White people. In the HSE 2004 [97], among both sexes,
African Caribbean men and women (15% and 21%
respectively) and Sub-Saharan Africans men and women
(32% and 45%) were more likely than the general popu-
lation men and women (8% and 14%) to be non-drink-
ers. African Caribbean and Sub-Saharan African men and
women were less likely than the general population to
report drinking on 3 or more days a week. African Carib-
bean and Sub-Saharan African men and women were less
likely than their general population counterparts to
exceed government recommendations on daily drinking
amounts (i.e. 4 units for men and 3 units for women).
They were also less likely than the general population to
binge drink. Despite the comparatively low rate in the
African decent groups, large proportions of African Carib-
bean men (20%) and Sub-Saharan African men (19%)
drank enough to be classified as binge drinkers. Low prev-
alence of alcohol consumption has also been reported
among African Surinamese men and women than among
their White-Dutch counterparts in the Netherlands [98].
The contribution of alcohol consumption to ethnic differ-
ences in CVD is unclear. Studies indicate that low levels of
consumption can have a protective effect against CVD
[123,124]. It is possible that the relatively low prevalence
of alcohol consumption among populations of AfricanPage 10 of 17
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of CVD.
Causation
The explanations for the low prevalence of alcohol con-
sumption among populations of African descent in
Europe are unclear. Cultural and religious differences in
the perception of alcohol use may play a role. For exam-
ple, Islam prohibits alcohol use. Some African descent
people in Europe are Muslims and therefore may not
drink alcohol at all while others may drink but not report
it for fear of stigmatisation [125].
Management
Treatment for alcohol dependence benefits both individ-
ual and society by improving individual health, produc-
tivity and quality of life. Although alcohol use is
comparatively low in populations of African descent, large
proportions of African Caribbean and Sub-Saharan Afri-
can men still consume more than the government recom-
mended daily drinking amounts and therefore need to be
targeted for preventive care and advice on alcohol moder-
ation [126].
Psychosocial stressors
Burden
Psychosocial stress is a risk factor for CVD morbidity and
mortality [28]. Research on ethnic differences in psycho-
social stress has produced largely conflicting results
[27,127-130]. In Shaw et al's study, anxiety disorders were
less common among African Caribbeans than among
White people. Depressive disorders were, however, more
common among African Caribbean women than White
women [127]. Weich and colleagues found no differences
in the prevalence of anxiety and depression between Afri-
can Caribbeans and White people [128]. Wadsworth and
colleagues' recent study, by contrast, showed that more
African Caribbean respondents reported high work stress
than either White counterpart [129]. In the HSE 1999, the
proportion of African Caribbean women with high
GHQ12 was significantly greater than women in the gen-
eral population [27]. More recently, Maynard and col-
leagues assessed psychosocial well-being among youth of
African and European descent in the UK, and found that
African boys and girls reported the most favourable psy-
chological wellbeing compared with their European
counterparts [130]. Others have also found important dif-
ferences within the African groups. In Maginn and col-
leagues' study, the rates of common psychological
problems as assessed by GHQ were lower in Sub-Saharan
African patients than in White patients, but there were no
differences between African Caribbean and White patients
in the UK [131].
Causes
The reasons for these inconsistent results are unclear
although others have argued that the screening instru-
ments in these studies may not be valid among these pop-
ulations [132]. These inconsistent results are surprising
given the higher rates of factors that may influence psy-
chosocial stressors such as discrimination, high rate of
unemployment, poverty, poor housing and lack of social
support [27,97,125,133]. Evidence suggests that experi-
ence of racism is central to the lives of many ethnic minor-
ity people [125]. Findings from the UK Fourth National
Survey of Ethnic Minorities showed widespread experi-
ences of racial harassment and discrimination among eth-
nic minority people in the UK [125]. There was also a
widespread belief that employers discriminated against
ethnic minority job applicants [133]. The reported racial
discrimination among African Caribbean female respond-
ents was strongly associated with perceived work stress
[129]. Similar findings have also been reported among
African Americans in the USA. One study found that
eighty percent of African American respondents in a USA
study reported experiencing racial discrimination at some
time in their lives [134]. Many of populations of African
descent in Europe are also socially isolated. In HSE 1999,
African Caribbean men and women were more likely than
men and women in the general population to be classified
as having a severe lack of social support [27].
Management
Recent findings indicate a significant level of unmet need
for the treatment of psychosocial disorders and variable
contact with general practitioners (GP) [135]. The increas-
ing cultural and social diversity in Europe will affect need
and access. Much attention has been paid to psychotic dis-
orders among ethnic minority groups especially among
African Caribbeans, but rather less attention has been
paid to common mental health problems [131].
Evidence suggests that patients of African descent attend
their GPs for consultations as frequently as White patients
[2], but are much less likely to be referred for psychologi-
cal therapies [136]. Evidence also suggests important dif-
ferences within the African groups and emphasise the
need to distinguish between these groups if progress is to
be made on this topic. In Marginn et al's study [131], the
detection and management of common mental disorders
in African Caribbean patients were similar to that in White
patients, but the Sub-Saharan African patients were less
likely to be detected and to receive active management
compared with White patients. The difference observed
between the two African populations may reflect cultural
differences between these groups. Sub-Saharan Africans
with psychological problems may be less likely than their
Caribbean counterparts to attend their GP, and may be
less willing to speak to them about these problems [136].Page 11 of 17
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ates the need to recognise the important heterogeneity
within populations of African descent in Europe [13].
Emerging vascular risk factors
Traditional risk factors may not explain all cardiovascular
events that occur. Epidemiological studies have explored
a range of novel risk factors in an attempt to improve the
prediction of future CVD. These novel factors include
markers of inflammation and haemostasis. Of these fac-
tors lipoprotein(a) levels, total plasma homocysteine lev-
els; fibrinolytic function as assessed by levels of tissue-
type plasminogen activator and plasminogen activator
inhibitor antigens; and inflammatory markers, such as
fibrinogen and high sensitivity C-reactive protein (CRP)
have received most attention [137]. Differences in
biomarkers for inflammation and haemostasis might con-
tribute to the observed ethnic differences in cardiovascu-
lar risk [138]. Data relating these novel factors to CVD risk
principally come from White populations with limited
information available across ethnic groups and particu-
larly among populations of African descent in Europe.
Some data from the UK suggest no apparent differences in
CRP concentrations [139,140], but fibrinogen levels have
been demonstrated to be lower in both West Africans and
African Caribbeans than in their European counterparts in
the UK [141]. A population-based study of multiethnic
middle-aged men and women in the UK found slightly
lower levels of circulating total homocysteine in both
West Africans and African Caribbeans living in England
compared to White people [142]. There is a clear need to
include more people from ethnic minority backgrounds
in future studies on these novel factors to improve on the
current evidence available.
Access and quality of care
Inequalities in access to and quality of care might also
partly contribute to the observed high prevalence of
stroke, hypertension and diabetes in populations of Afri-
can descent in Europe. The UK data suggest that in gen-
eral, a high proportion of people from most ethnic groups
appear to be registered with a general practitioner – with
registration rates of 99–100%, except for relatively low
registration rate in African Caribbean men (96%)
[143,144]. GP consultation rates have also been shown to
be higher in all ethnic groups than in the UK general pop-
ulation except for Chinese [143,145-147]. The Dutch data
also suggest higher GP consultation rates in all ethnic
minority groups than in White-Dutch group [148,149].
Despite the higher GP consultation rates and free univer-
sal health care system at the point of access, a population-
based study conducted to assess the quality of diabetes
care and intermediate clinical outcomes observed that
African Caribbean were significantly less likely to meet
national treatment targets for diabetes, BP and total cho-
lesterol compared to the White British group [90,150].
Information on differences in health care use regarding
specialised procedures such as cardiac catheterization,
coronary-artery bypass graft surgery, angioplasty and
carotid endarterectomy is very limited in Europe. Evi-
dence from the USA shows important differences in these
procedures between African American and White Ameri-
cans [151-153]. A study of residents in the ARIC study
communities found African Americans hospitalised for
definite MI to be two to three times less likely than White
Americans to have received invasive cardiac procedures
[151]. The differences in the rate of procedures received by
African Americans and White Americans persisted even
when the effects of disease prevalence, co-morbidities and
other covariates had been taken into account. There is a
clear need for further studies to determine whether ethnic
inequalities in specialised invasive procedures exist, and if
so, the extent to which these differences in these proce-
dures contribute to CVD morbidity and mortality risk dif-
ferentials. Current evidence suggests that ethnic minority
groups are under-represented in clinical trials especially in
Europe [154,155]. Ranganathan and Bhopal's systematic
review shows a shortage of information from cardiovascu-
lar cohort studies on ethnic minority populations in
Europe [155].
It is worth mentioning that the cause of inequalities in
access to services may depend on a wide range of factors
including knowledge of services and how to use them,
health beliefs and attitudes, language barriers, the sensi-
tivity of services to differing needs and the quality of care
provided. These raise the key issues for health profession-
als of effective communication, awareness of attitudes,
culture, stereotyping and racism within consultations and
broader aspects of health service delivery for ethnic
minority groups [156,157].
Strengths and limitation
The main strength of our current paper is that it provides
a comprehensive overview of the current understanding of
the epidemiology of vascular disease and related risk fac-
tors among populations of African descent in Europe.
There are also limitations. We carried out a comprehen-
sive review of literature but did not systematically assess
the quality of papers as would be done in a systematic
review. Nonetheless, we had been fairly careful in ensur-
ing that all major papers relevant to the issue have been
cited. Many of the conclusions were also based on pub-
lished systematic reviews and meta-analyses. Most of the
studies came from only the UK and the Netherlands.
Given the important heterogeneity within populations of
African descent, there is an urgent need for studies among
these populations living in other European countries.
Data are also scant on some aspect of CVD and risk factor
such as the emerging risk factors, management of somePage 12 of 17
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ing specialised procedures. In addition, the mortality data
are largely based on pragmatic categories such as country
of birth, which can be misleading [158]. Country of birth
may reflect ethnicity reasonably well among some ethnic
groups [17], but is likely to be an unreliable proxy meas-
ure of ethnicity for other groups. The Dutch Surinamese
population, for example, is composed of multiple ethnic-
ities (African descent, South Asian descent and others)
[17]. As a result, the mortality data among African-Suri-
namese population in the Netherlands is not reliable. In
addition, very little information was available on addi-
tional indicators of ethnicity, including migration history
and length of stay in the residing country. This type of
information is necessary to obtain more insight into the
background of the patterns of ethnic differences, includ-
ing issues such as the way these differences develop with
increasing length of stay.
Conclusion
This outline clearly indicates that hypertension and diabe-
tes are higher in populations of African descent than in
their European counterparts, which may contribute to the
high rate of stroke among these populations in Europe.
The relatively low rate of CHD may be explained by the
low rates of other risk factors including a more favourable
lipid profile and the low prevalence of smoking. The risk
factors are changing, and on the whole, getting worse
especially among African women. The UK African descent
populations are significantly less likely to meet national
treatment targets for diabetes and BP compared to the
White British group. The BP control among African Suri-
namese in the Netherlands, especially men, is unaccepta-
bly low. The high rate of stroke will decline if high BP
control improves among these populations in Europe.
These findings clearly indicate that urgent action is
needed in Europe to address these inequalities.
The effectiveness of CVD interventions in populations of
African descent health needs to be established. This will
require cohort studies and clinical trials to determine the
relative contribution of vascular risk factors in these
groups, and to help guide the prevention efforts. There is
also an urgent need for trials to evaluate clinical outcomes
among these populations in Europe. This is highly rele-
vant because preventive strategies developed and tested in
European populations may not apply to ethnic minority
groups because of cultural differences, language barriers,
poor education levels and poor social relations. Strategies
may have to be specifically developed, validated and
assessed to consider both cultural acceptability, which is
likely to affect uptake and compliance, and underlying
susceptibility, which may affect the effectiveness of pre-
ventive and therapeutic options in different ethnic groups.
Lastly, more efforts are also needed to improve data qual-
ity by recognizing the important heterogeneity within
African descent populations in Europe and between the
first and the second generations.
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